Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 254 a 273 di 500
Titolo Data di pubblicazione Autore(i) File
[Kinetic and immunological studies in human myeloma: clinical implications (author's transl)] 1979 PILERI A ;BOCCADORO M
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study 2019 Ferrero, Simone; Rossi, Davide; Rinaldi, Andrea; Bruscaggin, Alessio; Spina, Valeria; Eskelund, Christian W; Evangelista, Andrea; Moia, Riccardo; Kwee, Ivo; Dahl, Christina; Di Rocco, Alice; Stefoni, Vittorio; Diop, Fary; Favini, Chiara; Ghione, Paola; Mahmoud, Abdurraouf Mokhtar; Schipani, Mattia; Kolstad, Arne; Barbero, Daniela; Novero, Domenico; Paulli, Marco; Zamò, Alberto; Jerkeman, Mats; Gomez da Silva, Maria; Santoro, Armando; Molinari, Annalia; Ferreri, Andres; Grønbæk, Kirsten; Piccin, Andrea; Cortelazzo, Sergio; Bertoni, Francesco; Ladetto, Marco; Gaidano, Gianluca
Late deaths among five-year survivors of childhood cancer. A population-based study in Piedmont Region, Italy. 2006 DAMA E ;PASTORE G ;MOSSO ML ;FERRANTE D ;MAULE MM ;MAGNANI C ;MERLETTI F
LDH AS PREDICTIVE PARAMETER IN TREATMENT-NAIVE PATIENTS WITH TRISOMY 12 CHRONIC LYMPHOCYTIC LEUKEMIA 2017 Autore, F; Strati, P; Innocenti, I; Corrente, F; Trentin, L; Cortelezzi, A; Visco, C; Coscia, M; Cuneo, A; Gozzetti, A; Mauro, FR; Montillo, M; Gentile, M; Morabito, F; Molica, S; Falcucci, P; D'Arena, G; Murru, R; Vincelli, D; Galieni, P; Reda, G; Tisi, MC; Vitale, C; Rigolin, GM; Ferrajoli, A; Laurenti, L
LDH AS PREDICTIVE PARAMETER IN TREATMENT-NAIVE PATIENTS WITH TRISOMY 12 CHRONIC LYMPHOCYTIC LEUKEMIA 2017 Autore, F; Strati, P; Innocenti, I; Corrente, F; Trentin, L; Cortelezzi, A; Visco, C; Coscia, M; Cuneo, A; Gozzetti, A; Mauro, FR; Montillo, M; Gentile, M; Morabito, F; Molica, S; Falcucci, P; D'Arena, G; Murru, R; Vincelli, D; Galieni, P; Reda, G; Tisi, MC; Vitale, C; Rigolin, GM; Ferrajoli, A; Laurenti, L
Lenalidomide can be safely combined with chlorambucil and rituximab in older patients with chronic lymphocytic leukemia 2019 Vitale, Candida; Ferrajoli, Alessandra*
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia. 2015 Fiorcari S1; Martinelli S1; Bulgarelli J1; Audrito V2; Zucchini P1; Colaci E1; Potenza L1; Narni F1; Luppi M1; Deaglio S2; Marasca R3; Maffei R1.
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial 2019 Bringhen, Sara; D'Agostino, Mattia; Paris, Laura; Ballanti, Stelvio; Pescosta, Norbert; Spada, Stefano; Pezzatti, Sara; Grasso, Mariella; Rota-Scalabrini, Delia; De Rosa, Luca; Pavone, Vincenzo; Gazzera, Giulia; Aquino, Sara; Poggiu, Marco; Santoro, Armando; Gentile, Massimo; Baldini, Luca; Petrucci, Maria Teresa; Tosi, Patrizia; Marasca, Roberto; Cellini, Claudia; Palumbo, Antonio; Falco, Patrizia; Hájek, Roman; Boccadoro, Mario; Larocca, Alessandra
Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia. 2006 De Franceschi L;Daraio F;Filippini A;Carturan S;Muchitsch EM;Roetto A;Camaschella C
LONG TERM FOLLOW UP OF A COMPARISON OF NONMYELOABLATIVE ALLOGRAFTING WITH AUTOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA 2009 Bruno B; Sorasio R; Patriarca F; Mordini N; Allione B; Carnevale-Schianca F; Giaccone L; Festuccia M; Aglietta M; Levis A; Gallamini A; Fanin R; Palumbo A; Ciccone G; Boccadoro M
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma 2019 Maffini E.; Storer B.E.; Sandmaier B.M.; Bruno B.; Sahebi F.; Shizuru J.A.; Chauncey T.R.; Hari P.; Lange T.; Pulsipher M.A.; McSweeney P.A.; Holmberg L.; Becker P.S.; Green D.J.; Mielcarek M.; Maloney D.G.; Storb R.
LONG-TERM FOLLOW-UP IN VERY ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB FRONTLINE 2017 Crugnola, M; Latagliata, R; Breccia, M; Ferrero, D; Trawinska, MM; Castagnetti, F; Annunziata, M; Stagno, F; Tiribelli, M; Binotto, G; Fava, C; Crisa, E; Mansueto, G; Gozzini, A; Falzetti, F; Montefusco, E; Iurlo, A; Russo, S; Cedrone, M; Rossi, AR; Gugliotta, G; Pregno, P; Isidori, A; Mauro, E; Atelda, R; Giglio, G; Celesti, F; Sora, F; Storti, S; D'Addosio, AM; Galimberti, S; Orlandi, E; Calistri, E; Bocchia, M; Cavazzini, F; Cambrin, GR; Luciano, L; Abruzzese, E; Capodanno, I; Crugnola, M; Latagliata, R; Breccia, M; Ferrero, D; Trawinska, MM; Castagnetti, F; Annunziata, M; Stagno, F; Tiribelli, M; Binotto, G; Fava, C; Crisa, E; Mansueto, G; Gozzini, A; Falzetti, F; Montefusco, E; Iurlo, A; Russo, S; Cedrone, M; Rossi, AR; Gugliotta, G; Pregno, P; Isidori, A; Mauro, E; Atelda, R; Giglio, G; Celesti, F; Sora, F; Storti, S; D'Addosio, AM; Galimberti, S; Orlandi, E; Calistri, E; Bocchia, M; Cavazzini, F; Cambrin, GR; Luciano, L; Abruzzese, E; Capodanno, I
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients 2020 Baron F.; Efficace F.; Cannella L.; Willemze R.; Vignetti M.; Muus P.; Marie J.-P.; Ferrero D.; Fazi P.; Sala E.L.; Bourhis J.-H.; Fabbiano F.; Bosi A.; Sborgia M.; Martinelli G.; Wittnebel S.; Trisolini S.; Petti M.C.; Halkes C.J.M.; van der Velden W.J.F.M.; de Witte T.; Amadori S.; Zittoun R.A.; Suciu S.
Long-term molecular responses to imatinib inpatients with chronic myeloid leukemia: comparison between complete cytogeneticresponders treated in early and in late chronic phase. 2007 Palandri F, Iacobucci I, Quarantelli F, Castagnetti F, Cilloni D, Baccarani M; GIMEMA Working Party on CML.
Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia 2015 Gugliotta, G; Castagnetti, F; Breccia, M; Levato, L; D'Adda, M; Stagno, F; Tiribelli, M; Salvucci, M; Fava, C; Martino, B; Cedrone, M; Bocchia, M; Trabacchi, E; Cavazzini, F; Usala, E; Russo Rossi, A; Bochicchio, Mt; Soverini, S; Alimena, G; Cavo, M; Pane, F; Martinelli, G; Saglio, G; Baccarani, M; Rosti, G
Loss of surface HLA class I molecules in leukemic myeloblasts is correlated with an increased leukocyte concentration at onset. 1992 SAVOIA P ;D'ALFONSO S ;PERUCCIO D ;ISABELLA N ;FALDA M ;RESEGOTTI L ;RICHIARDI P
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. 2007 BERNENGO MG; QUAGLINO P; COMESSATTI A; ORTONCELLI M; NOVELLI M; LISA F; FIERRO MT
Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma. 2001 Palumbo A; Giaccone L; Bertola A; Pregno P; Bringhen S; Rus C; Triolo S; Gallo E; Pileri A; Boccadoro M
M-BCR breakpoint location does not predict survival in Philadelphia chromosome-positive chronic myeloid leukemia. 1992 ZACCARIA A ;MARTINELLI G ;BUZZI M ;ZUFFA E ;ZAMAGNI MD ;TESTONI N ;RUSSO D ;GUERRASIO A ;SAGLIO G ;TURA S
MACOP-B treatment for intermediate and high-grade non-Hodgkin's lymphomas at diagnosis and in relapse. 1990 Tarella C; Gallo E; Ferrero D; Badoni R; Carlesso N; Caracciolo D; Pileri A.
Mostrati risultati da 254 a 273 di 500
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile